ALL NEWS


18  February 2020

Pharmaceutical companies that market drugs will now fall under the ambit of the Drugs and Cosmetics Act (DCA), according to a notification issued by the Ministry of Health and Family Welfare (MoHFW).

This means they will be held liable if the drug is found to be spurious, or its quality i ...

17  February 2020

The Council for Healthcare and Pharma today cited the urgent need to strengthen the system for the treatment of cancers in children, in India.

Speaking on the occasion of the International Childhood Cancer Day, Dr Gurpreet Sandhu, President, Council for Healthcare and Pharma said, "Cancer in ...

11  February 2020

The dependence of pharmaceutical companies on China when it comes to active pharmaceutical ingredients (APIs), intermediates and other key starting materials is well documented. As per the USFDA, as of August 2019, up to 13 percent of manufacturing sites for APIs for drugs in the US market are locat ...

10  February 2020

Drug major Cipla has acquired the nutrition products portfolio from Mumbai-based Wanbury for an undisclosed sum.

The acquisition, aimed at strengthening Cipla’s women’s health segment, comprises four brands — CPink, CDense, Productiv, and Folinine. CPink is used to treat anaemia, CD ...

10  February 2020

Now that a case of infection by the novel coronavirus (2019-nCoV) has been flagged in India, central and state governments will be expected to try to ensure that its response system is strong, quick, and proactive in order to prevent the infection from spreading any further. The density of populatio ...

10  February 2020

Development of Vaccine Against New Coronavirus Progressing Well: U.S. Health Official WASHINGTON, A U.S. health official said last week that the development of vaccine against the coronavirus is going well, with "no glitches".

Anthony Fauci, director of the U.S. National Institute of Al ...

28  January 2020

The next Union budget is just around the corner. The Council for healthcare and Pharma (CHP) lauds the efforts of the Government and the vision of PM Narendra Modi in launching the visionary Ayushman Bharat and Jan Arogya programmes which aim to provide medical access and the right to health, to eve ...

04  January 2020

The Rs 14,000-crore diabetes drug market in the country is witnessing a churn with many patents reaching their expiry. For patients, that’s good news as far as medicine price is concerned. The diabetes segment has been growing faster than the country’s overall drug market.

At le ...

04  January 2020

Over the last several years, many a vision statement projected a robust trajectory for the pharmaceutical industry by the year 2020. The widely accepted projections held out by representatives of the Indian government and industry pegged the pharmaceutical segment at $55 billion by 2020. It is 2020. ...

02  January 2020

In what can be a game changer for the Indian pharmaceutical industry, the Ministry of Environment and Forests (MoEF) has cleared a proposal to allow drug manufacturers to tweak their product mix or raw materials used without a fresh environmental clearance as long as their pollution load remains con ...

02  January 2020

Around four months earlier, the US drugs regulator said it had found a cancer-causing impurity in some products containing ranitidine, a popular prescription for acidity.

That has meant a major quake within the Indian pharmaceutical industry, since a number of its prominent members sell v ...

01  January 2020

DoP officials, rather than district collectors, could be entrusted with job
Unable to recover a major chunk of the penalties levied on pharmaceutical companies for overpricing drugs, the Department of Pharmaceuticals (DoP) is mulling new models of recovery. As part of th ...

10  December 2019

Amid repeated regulatory scrutiny by different state-level authorities, online pharmacy companies are urging policymakers to speed up the release of the revised rules.

E-pharmacy companies TOI spoke to say the draft regulations on online sale of medicines were first released in August 20 ...

05  December 2019

NEW DELHI, India’s proposal to cap the trade margins available to drug distributors will not significantly hurt the profitability of pharmaceutical companies, Fitch Ratings said. Trade margin is the difference between the price at which manufacturers/importers sell to stockists and the price charg ...

05  December 2019

CDSCO yet to finalise regulations for online drug sales or e-pharmacies. India's drugs regulator has asked all states to enforce a court directive prohibiting online medicine sales, a senior government official said on Tuesday, raising industry concerns it could disrupt some online businesses.
...

05  December 2019

Washington: A division of the American Chemical Society (CAS), specialising in scientific information solutions, has launched Formulus , the world's largest collection of formulations sourced from journals, patents and product inserts in India.

The Formulus is the new one-stop shop for r ...

29  November 2019

French drugmaker Sanofi is considering a joint venture or outright sale of its consumer healthcare unit as it readies its new strategic plan that is likely to be announced next month, a Reuters news report said.

Sanofi’s newly appointed CEO Paul Hudson plans to meet investors for a capi ...

29  November 2019

Novartis has agreed to buy New Jersey-headquartered The Medicines Company (MedCo) for US$ 9.7 billion. The buyout will give Novartis a late-stage PCSK9 therapy named inclisiran.

Inclisiran is a small, interfering RNA (siRNA) drug which works by blocking the synthesis of PCSK9 in the liver ...

29  November 2019

An analysis undertaken by BioPharma Dive has identified 31 troubled biopharma companies that are at highest risk of going bankrupt in the next 12 months. Amongst these are companies like Teva, Bausch Health, Endo International, Mallinckrodt and Amneal Pharmaceuticals. Also on high risk are small bio ...

29  November 2019

Viatris, it is. More than three months after Mylan said it would combine with Upjohn, a division of Pfizer, the two companies have announced that the new combined entity will be called Viatris. “Deriving it’s name from Latin, Viatris embodies the new company’s goal of providing a path — “V ...